Search research articles
Contact Us
Filters
Showing results (171-180 of 181) with videos related to
Page
of 19
Sort By:
Journal of Neurology
|
February 1, 2025
Neurological manifestations in patients with VEXAS syndrome
Charlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Chest
|
October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Raphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Journal of Internal Medicine
|
November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile
Valentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
Benjamin de Valence, Marion Delaune, Yann Nguyen, et al.
Journal of the American Academy of Dermatology
|
April 4, 2020
Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy
Grégoire Monseau, Océane Landon-Cardinal, Werner Stenzel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
Alessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Blood
|
May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX group
Vincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial
Anne-Claire Sanna, Ségolène Gendreau, Cyrielle Desnos, et al.
Journal of Autoimmunity
|
March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
Irene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Annals of the Rheumatic Diseases
|
May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Jerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 181) with videos related to
Sort By:
Page
of 19
Journal of Neurology
|
February 1, 2025
Neurological manifestations in patients with VEXAS syndrome
Charlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Chest
|
October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Raphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Journal of Internal Medicine
|
November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile
Valentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
Benjamin de Valence, Marion Delaune, Yann Nguyen, et al.
Journal of the American Academy of Dermatology
|
April 4, 2020
Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy
Grégoire Monseau, Océane Landon-Cardinal, Werner Stenzel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
Alessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Blood
|
May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX group
Vincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial
Anne-Claire Sanna, Ségolène Gendreau, Cyrielle Desnos, et al.
Journal of Autoimmunity
|
March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
Irene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Annals of the Rheumatic Diseases
|
May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Jerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Page
of 19